Related Experiment Video
Updated: Aug 7, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
The Progression of Pathophysiology of Moyamoya Disease
Tongyu Chen1, Wei Wei1,2, Jin Yu1
1Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan , Hubei Province , China.
Abstract:
Moyamoya disease (MMD) is a chronic steno-occlusive cerebrovascular disease that often leads to hemorrhagic and ischemic strokes; however, its etiology remains elusive. Surgical revascularization by either direct or indirect bypass techniques to restore cerebral hypoperfusion is the treatment of choice to date. This review aims to provide an overview of the current advances in the pathophysiology of MMD, including the genetic, angiogenic, and inflammatory factors related to disease progression. These factors may cause MMD-related vascular stenosis and aberrant angiogenesis in complex manners. With a better understanding of the pathophysiology of MMD, nonsurgical approaches that target the pathogenesis of MMD may be able to halt or slow the progression of this disease.
Insights
Moyamoya disease (MMD) is a rare cerebrovascular condition causing strokes. This review explores genetic, angiogenic, and inflammatory factors in MMD pathophysiology to guide future non-surgical treatments.
Area of Science:
- Neurology
- Vascular Biology
- Genetics
Background:
- Moyamoya disease (MMD) is a chronic steno-occlusive cerebrovascular disorder.
- MMD frequently results in hemorrhagic and ischemic strokes.
- The precise etiology of MMD remains largely unknown.
Approach:
- This review synthesizes current research on MMD pathophysiology.
- It examines genetic, angiogenic, and inflammatory factors contributing to disease progression.
- The complex interplay of these factors in vascular stenosis and aberrant angiogenesis is discussed.
Key Points:
- Genetic factors play a role in MMD development.
- Angiogenic processes are implicated in the disease's vascular abnormalities.
- Inflammatory pathways are associated with MMD progression.
Conclusions:
- Understanding MMD pathophysiology is crucial for developing new therapies.
- Targeting the underlying pathogenesis may offer non-surgical treatment options.
- Future research could lead to interventions that halt or slow MMD progression.
More Related Videos
06:54A Model for Encephalomyosynangiosis Treatment after Middle Cerebral Artery Occlusion-Induced Stroke in Mice
Published on: June 22, 2022
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction
Mitral Stenosis I: Introduction
Myocarditis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...